About Questcor Pharmaceuticals

Questcor Pharmaceuticals, Inc. (Questcor) markets H.P. Acthar Gel (repository corticotropin injection), an injectable drug that is approved for the treatment of certain disorders with an inflammatory component, including the treatment of exacerbations associated with multiple sclerosis (MS), and the treatment of nephrotic syndrome. H.P. Acthar Gel (Acthar) – more... 

Reviews

Overall

4.3
Based on 6 reviews
5 stars
4 stars
3 stars
2 stars
1 star
Work/Life Balance
Compensation/Benefits
Job Security/Advancement
Management
Culture
Claim this company page
Headquarters
Anaheim California, United States
Revenue
$798.9 Million
Employees
501 to 1,000
Industry
Links
Questcor Pharmaceuticals website